Drug
Rly 8161
Rly 8161: highest development phase Phase 1/2, developed by Relay Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Relay Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| RLY-8161 NCT07584226 | Phase 1/2 | Advanced NRAS-Mutant Melanoma |
Latest
Follow Rly 8161 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.